About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Raquel Delgado Gil. Predoctoral researcher Biomedical Research in Gynaecology. Vall d'Hebron Research Institute (VHIR).
Abstract: Endometriosis is a benign gynecological condition characterized by the presence of endometrial-like tissue outside the uterine cavity, affecting around one in ten reproductive-aged women. It commonly causes pelvic pain and infertility, yet diagnosis remains challenging. Current methods rely on imaging, which requires expert interpretation and varies in accuracy, or on laparoscopic surgery, now less frequent due to its invasiveness. These limitations result in diagnostic delays of 4–11 years, significantly affecting patients’ quality of life.Consequently, there is a need for finding new non-invasive, effective and easy to use diagnostic approaches. Cervical fluid reflects the endometrial environment and has already been studied in other gynecological conditions, arising as a potential non-invasive source of endometriosis biomarkers. The aim of our study is to identify, verify and clinically validate biomarkers for endometriosis diagnosis in cervical fluid using proteomic techniques. Host: Eva Colás Ortega. Head of group Biomedical Research in Gynaecology. Vall d'Hebron Research Institute (VHIR).
